Find in Library

Abstract Bing‐Neel syndrome (BNS) remains a rare complication of Waldenstrom Macroglobulinemia. Given the paucity of this disease, treatment guidelines are based on small clinical trials with limited participants. Here, we present a case of primary CNS diffuse large B‐cell lymphoma masqueraded as BNS that developed while on ibrutinib therapy.